Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M466Revenue $M68.5Net Margin (%)-59.0Altman Z-Score12.7
Enterprise Value $M271EPS $-1.4Operating Margin %-49.1Piotroski F-Score4
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-49.1Higher ROA y-yN
Price/Book2.410-y EBITDA Growth Rate %--Quick Ratio14.0Cash flow > EarningsY
Price/Sales7.25-y EBITDA Growth Rate %--Current Ratio14.0Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %-131.3ROA % (ttm)-17.1Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-19.1Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M28.9ROIC % (ttm)-262.7Gross Margin Increase y-yN

Gurus Latest Trades with NLNK

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NLNKFirst Eagle Investment 2015-12-31 Reduce-0.01%$32.73 - $44.93
($36.21)
$ 16.92-53%Reduce -4.44%1,793,200
NLNKJoel Greenblatt 2015-09-30 Sold Out -0.46%$35.26 - $55.01
($48.76)
$ 16.92-65%Sold Out0
NLNKFirst Eagle Investment 2015-09-30 Add0.01%$35.26 - $55.01
($48.76)
$ 16.92-65%Add 9.13%1,876,600
NLNKJoel Greenblatt 2015-06-30 Add0.15%$36.55 - $56.87
($47.33)
$ 16.92-64%Add 48.51%1,244,856
NLNKFirst Eagle Investment 2015-06-30 Add0.03%$36.55 - $56.87
($47.33)
$ 16.92-64%Add 20.19%1,719,600
NLNKJoel Greenblatt 2015-03-31 Buy 0.35%$31.95 - $56.4
($43.06)
$ 16.92-61%New holding838,221
NLNKFirst Eagle Investment 2015-03-31 Add$31.95 - $56.4
($43.06)
$ 16.92-61%Add 1.73%1,430,700
NLNKFirst Eagle Investment 2014-03-31 Add0.02%$21.38 - $50.4
($33.68)
$ 16.92-50%Add 28.35%1,161,805
NLNKFirst Eagle Investment 2013-09-30 Add0.01%$15.78 - $20.08
($17.83)
$ 16.92-5%Add 21.32%778,354
NLNKFirst Eagle Investment 2013-06-30 Add0.02%$11.27 - $22.56
($15.73)
$ 16.928%Add 95.04%641,554
NLNKFirst Eagle Investment 2013-03-31 Buy 0.01%$11.4 - $12.7
($12.08)
$ 16.9240%New holding328,939
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NLNK is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


NLNK: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Link Charles J. Jr.Chairman of the Board and CEO 2016-02-03Sell25,000$24.16-29.97view
HENNEMAN JOHN B IIIEVP, CFO 2016-01-05Sell175$35.74-52.66view
Wiley BrianVP of Business Development 2016-01-05Sell1,295$34.99-51.64view
Vahanian Nicholas N.President, Chief Medical Offic 2016-01-05Sell3,011$35.06-51.74view
Vahanian Nicholas N.President, Chief Medical Offic 2015-09-11Sell10,000$51.19-66.95view
Vahanian Nicholas N.President, Chief Medical Offic 2015-08-03Sell10,000$51.77-67.32view
Vahanian Nicholas N.President, Chief Medical Offic 2015-07-14Sell20,000$51.14-66.91view
Saluri JosephDirector 2015-07-13Sell5,000$50.42-66.44view
Ramsey William J.Quality Assurance Officer 2015-06-01Sell2,500$42.69-60.37view
HENNEMAN JOHN B IIIEVP, CFO 2015-05-14Buy3,000$37.3-54.64view

Quarterly/Annual Reports about NLNK:

News about NLNK:

Articles On GuruFocus.com
First Eagle Investment Adds to Stake in NewLink Genetics Feb 03 2016 
These Companies Show High Profit and Low Debt Jun 17 2015 
When A Stock Doubles, Don’t Trim It Automatically May 27 2015 
Greenblatt's Top Buys During First Quarter May 22 2015 
NewLink Genetics Corporation Offers a Risky Way to Generate Income Sep 11 2013 
Weekly CEO Sells Highlight: Universal Insurance Holdings Inc, Avanir Pharmaceuticals Inc, Bel Fuse I Jun 30 2012 

More From Other Websites
NewLink Genetics Reports First Quarter 2016 Financial Results Apr 29 2016
NewLink reports 1Q loss Apr 29 2016
NewLink reports 1Q loss Apr 29 2016
NEWLINK GENETICS CORP Files SEC form 8-K, Results of Operations and Financial Condition Apr 29 2016
NewLink Genetics Reports First Quarter 2016 Financial Results Apr 29 2016
Q1 2016 NewLink Genetics Corp Earnings Release - Before Market Open Apr 29 2016
NEWLINK GENETICS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 25 2016
NewLink Genetics Awarded $21.6 Million Contract Option by BARDA for Ebola Vaccine Development Apr 25 2016
NewLink Genetics Awarded $21.6 Million Contract Option by BARDA for Ebola Vaccine Development Apr 25 2016
NewLink Genetics to Host Its First Quarter 2016 Earnings Conference Call on April 29, 2016 Apr 21 2016
NewLink Genetics to Host Its First Quarter 2016 Earnings Conference Call on April 29, 2016 Apr 21 2016
NEWLINK GENETICS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 15 2016
NewLink Genetics Receives $2.8 Million Award from DTRA to Develop a Multivalent Filovirus Vaccine Apr 15 2016
NewLink Genetics Receives $2.8 Million Award from DTRA to Develop a Multivalent Filovirus Vaccine Apr 15 2016
ETF’s with exposure to NewLink Genetics Corp. : April 14, 2016 Apr 14 2016
NewLink Genetics to Participate in Two Upcoming Investor Conferences Apr 06 2016
NewLink Genetics to Participate in Two Upcoming Investor Conferences Apr 06 2016
NEWLINK GENETICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement Mar 24 2016
Coverage initiated on NewLink Genetics by Robert W. Baird Mar 23 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)